BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perez DM. Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure. Int J Mol Sci 2021;22:5783. [PMID: 34071350 DOI: 10.3390/ijms22115783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Papay RS, Macdonald JD, Stauffer SR, Perez DM. Characterization of a novel positive allosteric modulator of the α1A-Adrenergic receptor. Current Research in Pharmacology and Drug Discovery 2022. [DOI: 10.1016/j.crphar.2022.100142] [Reference Citation Analysis]
2 Munley JA, Kelly LS, Mohr AM. Adrenergic Modulation of Erythropoiesis After Trauma. Front Physiol 2022;13:859103. [PMID: 35514362 DOI: 10.3389/fphys.2022.859103] [Reference Citation Analysis]
3 Shao-Mei W, Li-Fang Y, Li-Hong W. Traditional Chinese medicine enhances myocardial metabolism during heart failure. Biomed Pharmacother 2021;146:112538. [PMID: 34922111 DOI: 10.1016/j.biopha.2021.112538] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]